Company / Operating Cash Flow per Share
Biogen Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$15.21
FY2025
5-year range
$9.08 / $20.89
FY2021-FY2025
Trend
-23.8%
vs FY2024
Sector context
#7 of 210
Health Care
What the data says
Among 210 Health Care companies, Biogen is in the top 3% for operating cash flow per share. Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $9.08 in FY2022 to $33.47 in FY2019.
Based on SEC 10-K filings.
15.21 in FY2025 with a 5-year CAGR of -6.6%. Top quartile in the Health Care sector.
Improved from $10.53 to $15.21 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +18.8%
- 5-Year CAGR
- -6.6%
- 10-Year CAGR
- -
Sector benchmark
+187.1% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 23.8% year-over-year.
- Ranks #7 out of 210 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2019.
- Lowest operating cash flow per share in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.21 | -23.8% |
| FY2024 | $19.97 | +89.7% |
| FY2023 | $10.53 | +15.9% |
| FY2022 | $9.08 | -56.5% |
| FY2021 | $20.89 | -2.6% |
| FY2020 | $21.45 | -35.9% |
| FY2019 | $33.47 | +16.8% |
| FY2018 | $28.66 | +36.0% |
| FY2017 | $21.08 | +0.5% |
| FY2016 | $20.98 | +25.6% |
As of FY2025 · SEC 10-K · Updated Mar 3, 2026